
3 janvier 2022
Advanced melanoma nivolumab–ipilimumab outcomes may be poorer in women
By Lynda Williams, medwireNews Reporter
3 janvier 2022
Advanced melanoma nivolumab–ipilimumab outcomes may be poorer in women
By Lynda Williams, medwireNews Reporter